Home › Funds › Propel Bio Management, LLC › SGP
Propel Bio Management, LLC position in SGP
SPYGLASS PHARMA INC · Health Care
Propel Bio Management, LLC reported holding 41,418 shares of SGP (SPYGLASS PHARMA INC) in its Q3 2026 13F filing — a position valued at US$1.1M, representing 0.57% of its reported portfolio and ranking #29 among its reported holdings. Propel Bio Management, LLC first reported this position in Q3 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Propel Bio Management, LLC's SGP position evolved
Propel Bio Management, LLC first disclosed a stake in SGP in Q3 2026 at 41,418 shares (US$1.1M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 41.42K | $1.08M | New |
About SGP and 13F data
SGP (SPYGLASS PHARMA INC) is a Health Care company. 70 other funds we track also report a position in SGP — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$178.6M), NEA Management Company, LLC (US$164.6M), Sands Capital Alternatives, LLC (US$65.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SGP
- RA CAPITAL MANAGEMENT, L.P. 8.02M sh · $178.55M · Q2 2026
- NEA Management Company, LLC 7.39M sh · $164.55M · Q2 2026
- Sands Capital Alternatives, LLC 2.50M sh · $65.00M · Q3 2026
- Samsara BioCapital, LLC 2.11M sh · $46.97M · Q2 2026
- Vestal Point Capital, LP 670.00K sh · $14.91M · Q2 2026
More on Propel Bio Management, LLC
FAQ
How long has Propel Bio Management, LLC held SGP?
Propel Bio Management, LLC has disclosed SGP holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Propel Bio Management, LLC's current position in SGP?
As of Q3 2026, Propel Bio Management, LLC holds 41.42K shares of SGP (SPYGLASS PHARMA INC), valued at $1.08M, representing 0.57% of its reported portfolio and ranking #29.
Has Propel Bio Management, LLC been buying or selling SGP?
In the latest 13F filing (Q3 2026), Propel Bio Management, LLC newly opened its position in SGP.
Which other funds hold SGP?
Other major institutional holders of SGP include RA CAPITAL MANAGEMENT, L.P., NEA Management Company, LLC, Sands Capital Alternatives, LLC, among 70 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.